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osting by EAbstract Background: Oculocutaneous albinism (OCA) is a genetically heterogeneous group of
disorders characterized by the absence or reduced pigmentation of the skin, hair and eyes. To assess
the clinico-epidemiologic features of different forms of OCA among Egyptian patients, we per-
formed a retrospective study to determine the frequency, types, clinical presentation and associated
genomic errors in albino patients and their relatives consulting the Genetics Clinic, Pediatric Hos-
pital, Ain Shams University, Cairo, Egypt.
Methods: We used the outpatients index ﬁles to identify diagnosed cases of albinism referred from
the dermatologic and ophthalmologic departments with different genodermatoses over 43 year per-
iod. We used speciﬁcally designed data collection protocol forms to extract epidemiological and
clinical data from the patients medical records. These were entered into a computer database
and analyzed using standard statistical software.
Results: The occurrence rate of albinism in our study was 20.4% of genodermatoses patients and 1
per 5843 patients attending the Pediatric hospital. Consanguineous marriage was reported among
parents of 66.37% of patients and positive family history was reported in 46.01% of patients.
Complete OCA was detected in 48.59% of patients, partial albinism in 41.59% of patients andedical Genetics Center, Ain
20 26859398.
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168 A.F. Mohamed et al.syndromic albinism was detected in 7.96%. Associated genomic errors were detected in 36.28% of
our albino patients and seventy one multiple mutant genomic errors were deﬁned among relatives of
thirty seven index families of oculocutaneous albinism patients.
Conclusion: To the best of our knowledge, this preliminary study is the ﬁrst report of its kind from
Egypt. The high rate of parental consanguinity among the parents of our Egyptian albino patients
may account for the frequency of this genodermatosis in Egypt.
 2010 Ain Shams University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Albinism, derived from the Latin, albus, meaning white, is a
heterogeneous group of inherited disorders of melanin biosyn-
thesis characterized by a generalized reduction in pigmentation
of hair, skin and eyes [1].
Albinism may be isolated oculocutaneous albinism (OCA),
ocular or syndromic. OCA is considered isolated if it involves
only tissues that are normally pigmented. The four known
types of OCA (OCA1 to OCA4) are autosomal recessive disor-
ders associated with mutations of speciﬁc genes, TRY [2],
OCA2 (P) [3], TYRP1 [4–6] and MATP [7], respectively. How-
ever, other genes yet unidentiﬁed probably exist [8]. In ocular
albinism (OA), the clinical manifestations are limited to the
eyes and can be caused by mutations in OA1 gene located
on the X-chromosome, however, in autosomal recessive ocular
albinism (AROA), can be caused by mutations in OCA genes
[9–11]. In Southern Africa, brown OCA (BOCA) maps onto
the OCA2 locus on chromosome 15q [4]. In addition, OCA
is a phenotypic component of at least three syndromic disor-
ders: Hermansky–Pudlak syndrome (HPS), which can result
from mutations in eight known genes, most frequently HPS1
and HPS4; Chediak–Higashi syndrome (CHS), which results
from mutations in LYST (CHS1); and Griscelli syndrome
(GS), which can result from mutations in three known genes
(MYO5A; RAB27A, and MLPH) [12]. Syndromic forms of
albinism are associated with defects in the packaging of mela-
nin and other cellular proteins. As such they are distinct from
OCA, which are associated with defects in the production of
melanin [13].
The clinical spectrum of OCA varies with OCA1A being
the most severe type characterized by complete lack of melanin
production throughout life (tyrosinase negative, the critical en-
zyme required in melanin biosynthesis pathway), while the
milder forms OCA1B, OCA2, OCA3 and OCA4 show some
pigment accumulation over time [8] (tyrosinase positive), there
by producing some red-yellow photomelanin pigment that
gives rise to sandy colored hair and light brown irises [9]. Clin-
ical manifestations of OA include various degrees of congenital
nystagmus, iris hypopigmentation and translucency, reduced
pigmentation of the retinal pigment epithelium, foveal hypo-
plasia, reduced visual acuity and refractive errors, color vision
impairment and prominent photophobia. Misrouting of
the optic nerves is a characteristic ﬁnding, resulting in strabis-
mus and reduced stereoscopic vision [1]. Syndromic OCA such
as Chediak–Higashi and Hermansky–Pudlak syndrome also
manifest with extrapigmentary defects consisting of leucocyte,
platelet, pneumocyte and reticular cell dysfunction. Griscelli
syndrome can also manifest with immunodeﬁciency and neu-
rologic defects [14].
Herein, we conduct a retrospective study to determine the
frequency, types, clinical presentation and associated genomicerrors in albino patients and their relatives in the Genetics
Clinic, Pediatric Hospital, Ain Shams University. This hospital
is located in the northeast section of Cairo (the capital of
Egypt). It has a high standard of health care, so nearly all pa-
tients in this area attend this hospital for consultation. Also
patients come nearly from all governorates of Egypt to take
good health care. So, the frequency and characteristics of albi-
nism in this hospital will represent that in the general popula-
tion to a great extent.
2. Subjects and methods
The present study comprised 553 index patients with genoder-
matoses who were registered at Genetics Clinic, out of 660,280
attending the pediatric hospital, Ain Shams University, at the
interval 1966–2009.
All the patients were referred either through the ophthal-
mologic or dermatologic clinic for genetic counseling. They
were subjected to the following studies: detailed family history,
index pedigree design and clinical assessment of index patients
and their families.
We compiled data on six skin and hair parameters (skin col-
or, pigmentation pattern, color of scalp hair, eye brows, and
eye lashes, freckles and birthmarks), and eight eye and vision
parameters (photophobia, visual acuity, refractive value, nys-
tagmus, iris translucency, fundus pigmentation, foveal hypo-
plasia and misrouting of the optical pathways).
Since detailed ophthalmic and/or dermatologic data could
not be obtained on some of the old registered patients, the clin-
ical criteria to classify patients as complete oculocutaneous albi-
nism (OCA1A) were the presence of white hair and skin
throughout life. The group of partial oculocutaneous albinism
(OCA1B) patients included those who initially had white scalp
hair at birth but developed pigment in the ﬁrst decade of life [15].3. Results
3.1. Occurrence rate
Of 553 new genodermatoses patients presenting to the Genetics
unit, and 660,280 patients attending the Pediatric hospital,
during the period of the study, 113 patients (20.4%) had clin-
ically conﬁrmed diagnosis of albinism. The occurrence rate
was 20.4% of genodermatoses patients attending the Genetic
unit, and 1 per 5843 patients attending the Pediatric hospital,
Ain Shams University, Cairo, Egypt.
3.2. Epidemiological proﬁle
Of the 113 patients, 62 (54.86%) were males and 51 (45.13%)
were females giving a male to female ratio of 1.2:1. All patients
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1 month to 25 years. Consanguineous marriage was reported
among the parents of 75 patients (66.37%). Fifty-two out of
the 113 patients (46.01%) had a positive family history of albi-
nism (one or more of their family members, particularly sib-
lings, had albinism as the index patient).
3.3. Clinical ﬁndings (Table 1)
3.3.1. Clinical phenotypes
Oculocutaneous albinismwas detected in 104 patients (92.04%)
of whom, ﬁfty ﬁve patients (48.67%) had complete oculocutane-
ous albinism with white hair color, pinkish skin, red pupils,
reduced visual acuity, nystagmus and photophobia and forty
seven patients (41.59%) had partial oculocutaneous albinism
with white blond skin, light brown hair, reduced visual acuity,
nystagmus, photophobia, blue eyes. Ocular albinism was de-
tected in 2 patients (1.76%) with reduced visual acuity, nystag-
mus, photophobia, blue eyes.
Syndromic oculocutaneous albinism was detected in 9 cases
(7.96%): 2 cases (1.76%) had Hermansky–Pudluk syndrome; 2
cases (1.76%) had Cross syndrome and ﬁve cases (4.42%) had
Chediak–Higashi syndrome.
3.3.2. Other medical associations
We reported mental retardation in 19 cases (16.8%), seizures
in 14 cases (12.38%), Down syndrome in 2 cases (1.76%)
and deafmutism in 4 cases (3.53%).
3.3.3. Multiple mutant genomic errors (Table 2)
Seventy one multiple mutant genomic errors were deﬁned
among relatives of thirty seven index families (32.74%) of ocu-
locutaneous albinism.4. Discussion
There are no published reports in the medical literature about
the incidence of OCA and only few reports deal with the pig-
mentary disorders in Egypt [16,17]. Our study shows that the
occurrence rate of OCA was 20.4% of genodermatoses pa-
tients attending the Genetics unit, and 1 per 5843 patients
attending the Pediatric hospital, Ain Shams University, Cairo,
Egypt. OCA is considered to be a rare autosomal recessive
genodermatoses with a worldwide incidence of 1:17,000 [9].
The prevalence of albinism from several studies in South Afri-
ca, Tanzania and Nigeria ranged from as low as 1 in 15,000 in
the East Central state of Nigeria to as high as 1 in 1000 in the
Tonga Tribe of Zimbabwe [18–20] where it is considered a
public health issue. In our clinical observations, the frequency
of OCA in Egypt seems to be higher than that reported in the
medical literature and falls in a midway position between the
low and high ranges reported in various regions of Africa.
Prevalence of the different forms of albinism varies consid-
erably worldwide, partly explained by the different founder
mutations in different genes and the fact that it can be difﬁcult
clinically to distinguish between the different subtypes of albi-
nism among the large normal spectrum of pigmentation.
OCA2 is the most prevalent form worldwide [21]. However,
in our series OCA1 was the most prevalent type. All types of
OCA and ocular albinism in our study had similar ocular ﬁnd-
ings, including nystagmus, hypopigmentation of iris, reducedvisual acuity and sometimes a degree of color vision
impairment.
In our study, albinism associated with systemic pathology
such as HMP, Cross syndrome and Chediak–Higashi syn-
drome was reported in 2%, 2% and 5% of our patients,
respectively. The relationship of albinism and the systemic
manifestations that occur in HPS, CHS and appears to be re-
lated to the cellular machinery in the ribosomes involved with
vesicles and lysosome transport. Speciﬁcally the link between
immunodeﬁciencies and albinism involves the use of secretory
vesicles and lysosomes by the immune system [22].
In this study, there was a slight male preponderance, with a
male to female ratio of 1.2:1. However, it is reported that the
incidence of these albino diseases are equal in both sexes [4].
We could not ﬁnd any reason to account for this male prepon-
derance, but perhaps there is a predominance of males over
females in this region of Egypt [23]. Our study showed forty
six percent of patients had a positive family history and a high
proportion of patients with consanguineous parents (66.37%)
compared to 38% in the general population [24]. This high
consanguinity rate may account for the high occurrence rate
of autosomal recessive genodermatoses such as OCA in this
region.
Genealogic analysis of pedigrees of index patients with ocu-
locutaneous albinism revealed an apparently high incidence of
other genetic anomalies which manifested simultaneously or
segregated randomly among many of proband’s relatives.
The identiﬁcation of isolated albinism as well as isolated sen-
sory neural deafness or mental deﬁciency among certain index
kindreds, could advocate the possibility of linkage of mutant
gene loci mediating both types of anomalies.
Deafmutism was reported in 7.27% of our patients with
complete OCA1. Hereditary hearing impairment is frequently
found associated with pigmentary disorders in genetic diseases
such as Waardenburg syndrome, Tietz-Smith syndrome and
piebaldism. Nevertheless, in none of these syndromes are total
OCA and only partial albinism, ocular or cutaneous reported.
Linkage analysis with markers close to the four known OCA
loci excluded linkages to OCA1, OCA2 and OCA3 and homo-
zygosity in markers near OCA4 locus was observed. The com-
bined occurrence of deafness and albinism was due to
mutations in two different genes, showing autosomal recessive
inheritance and they resulted by chance from consanguineous
matings [25].
Mental retardation and seizures were also reported in
30.91% and 25.45% of our patients with complete OCA.
The albino were found to be more intellectually mature than
the controls but the control group showed slightly more diffuse
body image boundary differentiation than the albino group
[26]. However, White et al. [27] reported a 20 year old man
with tyrosinase-negative OCA, mental retardation, epilepsy,
sensory neural deafness, ataxia and Barter syndrome and
Budisteanu et al. [28] present a case of oculocutaneous albi-
nism in a child with associating multiple malformations (pre-
axial polydactyly, small penis, cardiac malformation) and
psychomotor retardation. Other disorders reported in the liter-
ature include meningomyelocele [29], and hydrocephalus, meg-
alocornea, retinal coloboma and cerebral anomalies [30].
The association of albinism with chromosomal abnormali-
ties like Down syndrome is considered co-incidental. However
there is a report about the occurrence of ocular albinism in a
female with dup X chromosome [31].
Table 1 Summary table of the clinico-epidemiological features of 113 patients with albinism.
Clinico-epidemiologic data Complete OCA Partial OCA OA Hermansky–Pudlak Cross syndrome Chediak–Higashi
No. &% No. &% No. &% No. &% No. &% No. &%
Patients No. 55 (100%) 47 (100%) 2 (100%) 2 (100%) 2 (100%) 5 (100%)
Egyptian Nationality 55 (100%) 47 (100%) 2 (100%) 2 (100%) 2 (100%) 5 (100%)
Sex: Male 29 (52.73%) 25 (53.19%) 2 (100%) 2 (100%) 1 (50%) 3 (60%)
Positive parental relationship 37 (67.27%) 30 (63.83%) – 2 (100%) 2 (100%) 4 (80%)
Positive family history 26 (47.27%) 21 (44.68%) 1 (50%) 2 (100%) – 2 (40%)
White hair color 55 (100%) – – – – –
Pinkish skin 55 (100%) – – – – –
White, blond – 47 (100%) 2 (100%) 2 (100%) 2 (100%) –
Light brown hair – 47 (100%) 2 (100%) 2 (100%) 2 (100%) –
Silvery sheen to the hair and skin – – – – – 5 (100%)
Red pupils 55 (100%) – – – – –
Reduced visual acuity 55 (100%) 47 (100%) 2 (100%) 2 (100%) 2 (100%) 5 (100%)
Nystagmus 55 (100%) 47 (100%) 2 (100%) 2 (100%) 2 (100%) 5 (100%)
Photophobia 55 (100%) 47 (100%) 2 (100%) 2 (100%) 2 (100%) 5 (100%)
Blue eyes – 47 (100%) 2 (100%) 2 (100%) 2 (100%) 5 (100%)
Prolonged bleeding – – – 2 (100%) – –
Immune deﬁciency – – – – – 5 (100%)
Neurologic complications – – – – – 5 (100%)
MR 17 (30.91%) – – – 2 (100%) –
Microphthalmia – – – – 2 (100%) –
Seizures 14 (25.45%) – – – – –
Deafmutism 4 (7.27%) – – – – –
Down syndrome 2 (3.64%) – – – – –
Albinism index families with deﬁnable MMGE 20 (36.36%) 16 (34.04%) – – 1 (50%) –
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Table 2 Multiple mutant genomic errors deﬁned among
relatives of 37/113 albinism index families.
MMGE No. %
Deﬁnable errors 43 60.56
Single gene errors 18 25.35
Optic atrophy 3 4.23
Squint 2 2.82
Congenital blindness 1 1.41
Congenital cataract 1 1.41
Insulin dependent diabetes mellitus 3 4.23
Polydactyly 1 1.41
G6PD deﬁciency 1 1.41
Epidermolysis bullosa 1 1.41
Deafmutism 4 5.63
Rubeinstein Tybi synd. 1 1.41
Chromosomal errors 1 1.41
Down syndrome 1 1.41
Multifactorial errors 24 33.80
Congenital heart disease 1 1.41
Bronchial asthma 1 1.41
Cleft palate 1 1.41
Seizures 9 12.68
Non Insulin dependent Diabetes mellitus 10 14.08
Hypertension 2 2.82
Non deﬁnable errors 28 39.43
Mental deﬁciency 12 16.90
Speech defect 7 9.86
Infertility 5 7.04
Vetiligo 1 1.41
Hydrocephalus 1 1.41
Short stature 1 1.41
Talipes equinovarus 1 1.41
Sum of traceable errors 71 100.00
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problems are generally not increased compared to those in
the general population. However, skin cancers may occur
and regular skin checks should be offered. Development and
intelligence are normal. Persons with OCA have normal fertil-
ity [21]. Most of our albino patients, attending our clinic were
in the age range of one month to 25 years. Other publications
in Africa report a relatively greater number of individuals with
albinism in the younger age groups (below 30 years). In the
East Central state of Nigeria, 89% of identiﬁed people with
albinism were in the age range of 0–30 years, while another
study reported that 77% were under the age of 20 in the same
Nigerian state. A mean age of 17.8 years was reported in Sowe-
to, South Africa. Also in Cameroon, Nigeria and Tanzania,
observations indicate a low number of people with albinism
in age groups above 30 [18].
In albino population, ocular problems are ubiquitous. In
some studies, visual difﬁculties have been reported to occur
in 100% of people with albinism. Due to the lack of retinal pig-
ment required for the normal development of the visual system
these individuals experience photophobia, myopia and other
visual problems including nystagmus and strabismus. Aside
from the visual handicaps, UV exposure is highly detrimental
to the hypopigmented skin. Lack of melanin predisposes this
population to severe skin damage. The majority of these le-
sions are in the most sun-exposed parts of the body such as
the face, ears, neck and shoulders. Skin lesions include sun-
burns, blisters, solar elastosis/keratosis, ephelides, lentiginosis,and superﬁcial ulcers. Ultimately, squamous cell, and less fre-
quently basal cell carcinomas may occur [18,21].
In addition to their health concerns, people with albinism
must also deal with psychological and social challenges. In
Nigeria, one study collected written accounts of people with
albinism. These individuals stated that they tended to be more
withdrawn from social situations to avoid being noticed. They
were more emotionally unstable and had less assertive person-
alities than people without albinism. Also, they considered
their society to be generally unkind and rejecting, even though
they did have close friends. Much of the social discrimination
appears to stem from the communities’ lack of education
about albinism’s etiology. Furthermore, their family members
may also experience discrimination from the community [18].
In conclusion, albinism, especially in Africa including
Egypt due to extreme sun exposure, is a condition that requires
further attention than in the past. In Egypt we need more pro-
gress in terms of medical and social care and we hope to fur-
ther increase the awareness of albinism throughout the
country in the future.5. Conﬂict of interest
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